• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血栓年龄作为体外生成的血小板-纤维蛋白血栓溶解效果的决定因素]

[Thrombus age as a determinant of lysis efficacy of in vitro produced platelet-fibrin thrombi].

作者信息

Beythien C, Terres W, Gutensohn K, Meinertz T

机构信息

Medizinische Klinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg.

出版信息

Z Kardiol. 1996 Sep;85(9):661-7.

PMID:8992809
Abstract

Thrombus age as a determinant of lysis efficacy has rarely been investigated. We developed an in vitro model to study the lysis of collagen induced platelet-fibrin-thrombi of different ages. Histologically, the thrombi were similar to those found in coronary vessels of patients deceased from acute myocardial infarction or unstable angina. After 10 (TA10), 30(TA30) und 60 (TA60) min of thrombus aging thrombolysis over 30 min with urokinase alone or in combination with prostaglandin E1 was started. The efficacy of lysis with urokinase alone decreased with increasing thrombus age. After 30 min of lysis with urokinase alone weight of TA10-thrombi was reduced by 16.4 +/- 1.2 mg, of TA30-thrombi by 11.5 +/- 0.9 mg (p < 0.001 vs TA10-thrombi) and of TA60-thrombi by 7.8 +/- 1.1 mg (p < 0.001 vs TA30, p < 0.0001 vs TA10-thrombi). The addition of prostaglandin Ei augmented lysis of TA10-thrombi, after 30 min of lysis thrombus weight was reduced by 17.3 +/- 1.2 mg (p < 0.01 vs urokinase alone). Lysis of 30 and 60 min old thrombi was nearly unaffected. Thus, thrombus age is a strong predictor of lysis efficacy of in vitro collagen induced platelet-fibrin-thrombi.

摘要

血栓形成时间作为溶栓疗效的决定因素鲜有研究。我们建立了一个体外模型,以研究不同形成时间的胶原诱导血小板 - 纤维蛋白血栓的溶解情况。组织学上,这些血栓与急性心肌梗死或不稳定型心绞痛死亡患者冠状动脉中发现的血栓相似。在血栓形成10分钟(TA10)、30分钟(TA30)和60分钟(TA60)后,开始用尿激酶单独或联合前列腺素E1进行30分钟的溶栓。单独使用尿激酶时,溶栓效果随血栓形成时间延长而降低。单独用尿激酶溶栓30分钟后,TA10血栓重量减少16.4±1.2毫克,TA30血栓减少11.5±0.9毫克(与TA10血栓相比,p<0.001),TA60血栓减少7.8±1.1毫克(与TA30相比,p<0.001;与TA10血栓相比,p<0.0001)。添加前列腺素E1可增强TA10血栓的溶解,溶栓30分钟后血栓重量减少17.3±1.2毫克(与单独使用尿激酶相比,p<0.01)。30分钟和60分钟形成的血栓溶解几乎不受影响。因此,血栓形成时间是体外胶原诱导血小板 - 纤维蛋白血栓溶解疗效的有力预测指标。

相似文献

1
[Thrombus age as a determinant of lysis efficacy of in vitro produced platelet-fibrin thrombi].[血栓年龄作为体外生成的血小板-纤维蛋白血栓溶解效果的决定因素]
Z Kardiol. 1996 Sep;85(9):661-7.
2
Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis.
Circulation. 1989 Jun;79(6):1309-14. doi: 10.1161/01.cir.79.6.1309.
3
A bispecific antifibrin-antiplatelet urokinase conjugate (BAAUC) induces enhanced clot lysis and inhibits platelet aggregation.
Thromb Haemost. 1999 Jul;82(1):109-14.
4
[Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].[兔体内重组组织型纤溶酶原激活剂(rt-PA)溶栓结果是否取决于血栓的红细胞和纤维蛋白含量?]
Rofo. 2004 Jan;176(1):98-105. doi: 10.1055/s-2004-814671.
5
Thrombus lysis by uPA, scuPA and tPA is regulated by plasma TAFI.尿激酶型纤溶酶原激活剂(uPA)、单链尿激酶型纤溶酶原激活剂(scuPA)和组织型纤溶酶原激活剂(tPA)介导的血栓溶解受血浆纤溶酶原激活剂抑制因子-2(TAFI)调控。
J Thromb Haemost. 2003 Sep;1(9):2000-7. doi: 10.1046/j.1538-7836.2003.00383.x.
6
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.纤溶酶原激活剂的纤维蛋白特异性影响纤维蛋白溶解效率及对超声的反应性:九种纤溶酶原激活剂的体外比较
Thromb Haemost. 1999 Apr;81(4):605-12.
7
Coronary thrombus composition: links with inflammation, platelet and endothelial markers.冠状动脉血栓组成:与炎症、血小板及内皮标志物的关联
Atherosclerosis. 2014 Dec;237(2):555-61. doi: 10.1016/j.atherosclerosis.2014.10.020. Epub 2014 Oct 18.
8
The features of thrombus in a microvessel injury model and the antithrombotic efficacy of heparin, urokinase, and prostaglandin E1.
Plast Reconstr Surg. 2003 Jun;111(7):2307-14. doi: 10.1097/01.PRS.0000060796.93369.27.
9
An experimental and theoretical study on the dissolution of mural fibrin clots by tissue-type plasminogen activator.组织型纤溶酶原激活剂溶解壁内纤维蛋白凝块的实验与理论研究
Biotechnol Bioeng. 2002 Feb 15;77(4):405-19.
10
The effect of flow on lysis of plasma clots in a plasma environment.血流对血浆环境中血浆凝块溶解的影响。
Thromb Haemost. 2000 Mar;83(3):469-74.

引用本文的文献

1
Can thrombus age guide thrombolytic therapy?血栓的形成时间能否指导溶栓治疗?
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S186-S196. doi: 10.21037/cdt.2017.11.05.